Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.4% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Technology | 6.04% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CNO Financial Group
CNO
$5.13B
| $1.32K | ﹤0.01% |
82,448
-55,778
| -40% | -$894K |
|
2877
Madison Square Garden
MSGS
$9.55B
| $1.32K | ﹤0.01% |
8,779
-373
| -4% | -$58.5K |
|
2878
iShares MSCI USA Momentum Factor ETF
MTUM
$26.5B
| $1.32K | ﹤0.01% |
8,934
-4,230
| -32% | -$604K |
|
2879
Weis Markets
WMK
$1.94B
| $1.32K | ﹤0.01% |
+27,414
| New | +$1.35M |
|
2880
Xenon Pharmaceuticals
XENE
$6.16B
| $1.32K | ﹤0.01% |
118,845
-49,151
| -29% | -$578K |
|
|
INWK
2881
DELISTED
InnerWorkings, Inc.
INWK
| $1.31K | ﹤0.01% |
439,926
+391,703
| +812% | +$1.01M |
|
2882
Factset
FDS
$9.73B
| $1.31K | ﹤0.01% |
3,922
-51,852
| -93% | -$17.9M |
|
2883
PUT
Accenture
ACN
$101B
| $1.31K | ﹤0.01% |
5,800
-7,300
| -56% | -$1.67M |
|
|
NPAUU
2884
DELISTED
New Providence Acquisition Corp. Unit
NPAUU
| $1.31K | ﹤0.01% |
124,961
| – | – |
|
|
GOCO
2885
DELISTED
GoHealth
GOCO
| $1.31K | ﹤0.01% |
+6,687
| New | +$1.61M |
|
2886
Geron
GERN
$866M
| $1.3K | ﹤0.01% |
750,274
+734,246
| +4,581% | +$1.36M |
|
2887
Apollo Global Management
APO
$75.1B
| $1.3K | ﹤0.01% |
29,129
+14,522
| +99% | +$699K |
|
|
QVCGA
2888
DELISTED
QVC Group Inc Series A
QVCGA
| $1.3K | ﹤0.01% |
3,629
+2,001
| +123% | +$947K |
|
2889
PUT
Kohl's
KSS
$2.27B
| $1.3K | ﹤0.01% |
70,100
+10,100
| +17% | +$214K |
|
2890
Global Industrial
GIC
$1.42B
| $1.3K | ﹤0.01% |
54,178
-61,615
| -53% | -$1.33M |
|
2891
Astrana Health
ASTH
$1.75B
| $1.29K | ﹤0.01% |
+72,211
| New | +$1.25M |
|
2892
Andersons Inc
ANDE
$2.58B
| $1.29K | ﹤0.01% |
67,464
-244,564
| -78% | -$4.03M |
|
2893
iShares MSCI Turkey ETF
TUR
$213M
| $1.29K | ﹤0.01% |
65,405
+28,233
| +76% | +$600K |
|
|
HPX.WS
2894
CALL
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
| $1.29K | ﹤0.01% |
+131,250
| New | +$116K |
|
2895
Mohawk Industries
MHK
$9.15B
| $1.29K | ﹤0.01% |
13,233
+9,443
| +249% | +$849K |
|
|
TWTR
2896
CALL
DELISTED
Twitter, Inc.
TWTR
| $1.29K | ﹤0.01% |
29,000
-70,200
| -71% | -$2.69M |
|
2897
DHT Holdings
DHT
$2.91B
| $1.29K | ﹤0.01% |
249,932
-615,225
| -71% | -$3.4M |
|
|
ITCI
2898
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.28K | ﹤0.01% |
50,000
+25,000
| +100% | +$570K |
|
|
TAST
2899
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.28K | ﹤0.01% |
198,949
+34,000
| +21% | +$211K |
|
|
FSR
2900
DELISTED
Fisker Inc.
FSR
| $1.28K | ﹤0.01% |
88,953
-1,357,700
| -94% | -$18.5M |
|
Similar funds
Millennium Management's Q3 2020 Portfolio in Review
As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Millennium Management opened 989 new positions and closed 724 in Q3 2020.
- Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.